Fidelity Investments’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,716,836
| Closed | -$104M | – | 4475 |
|
|
2020
Q3 | $104M | Sell |
5,716,836
-4,894,782
| -46% | -$88.8M | 0.01% | 888 |
|
|
2020
Q2 | $145M | Sell |
10,611,618
-85,501
| -0.8% | -$1.17M | 0.02% | 725 |
|
|
2020
Q1 | $153M | Sell |
10,697,119
-99,021
| -0.9% | -$1.42M | 0.02% | 598 |
|
|
2019
Q4 | $183M | Sell |
10,796,140
-544,146
| -5% | -$9.22M | 0.02% | 681 |
|
|
2019
Q3 | $175M | Sell |
11,340,286
-899,203
| -7% | -$13.8M | 0.02% | 671 |
|
|
2019
Q2 | $287M | Sell |
12,239,489
-813,575
| -6% | -$19.1M | 0.03% | 515 |
|
|
2019
Q1 | $370M | Sell |
13,053,064
-328,442
| -2% | -$9.3M | 0.04% | 403 |
|
|
2018
Q4 | $403M | Buy |
13,381,506
+523,834
| +4% | +$15.8M | 0.06% | 345 |
|
|
2018
Q3 | $450M | Buy |
12,857,672
+402,289
| +3% | +$14.1M | 0.05% | 361 |
|
|
2018
Q2 | $295M | Buy |
12,455,383
+2,447,367
| +24% | +$58M | 0.03% | 505 |
|
|
2018
Q1 | $256M | Buy |
10,008,016
+26,772
| +0.3% | +$686K | 0.03% | 586 |
|
|
2017
Q4 | $173M | Buy |
9,981,244
+1,212,675
| +14% | +$21.1M | 0.02% | 745 |
|
|
2017
Q3 | $243M | Buy |
+8,768,569
| New | +$243M | 0.03% | 604 |
|